Active surveillance for intermediate risk prostate cancer could be risky for the patient

Kim Moretti^{1

2

3

4}

Affiliations

¹ Australian Centre for Precision Health, School of Health Sciences, Division of Health Sciences, University of South Australia, Adelaide, Australia. kim@theurologist.net.au.
² Faculty of Medicine Nursing and Health Sciences, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia. kim@theurologist.net.au.
³ Discipline of Surgery, University of Adelaide, Adelaide, Australia. kim@theurologist.net.au.
⁴ South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC), Adelaide, Australia. kim@theurologist.net.au.

Comment

Kim Moretti. World J Urol. 2022 Apr.

. 2022 Apr;40(4):1079-1080.

doi: 10.1007/s00345-021-03767-6. Epub 2021 Jul 1.

Kim Moretti^{1

2

3

4}

¹ Australian Centre for Precision Health, School of Health Sciences, Division of Health Sciences, University of South Australia, Adelaide, Australia. kim@theurologist.net.au.
² Faculty of Medicine Nursing and Health Sciences, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia. kim@theurologist.net.au.
³ Discipline of Surgery, University of Adelaide, Adelaide, Australia. kim@theurologist.net.au.
⁴ South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC), Adelaide, Australia. kim@theurologist.net.au.

No abstract available

Comment on

Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.
Meissner VH, Woll M, Ankerst DP, Schiele S, Gschwend JE, Herkommer K. Meissner VH, et al. World J Urol. 2021 Oct;39(10):3763-3770. doi: 10.1007/s00345-021-03717-2. Epub 2021 May 10. World J Urol. 2021. PMID: 33973043 Free PMC article.

1. Meissner VH, Woll M, Ankerst DP, Schiele S, Gschwend JE, Herkommer K (2021) Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance. World J Urol. https://doi.org/10.1007/s00345-021-03717-2 - DOI - PubMed - PMC
1. Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB et al (2017) Prostate cancer—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(3):245–253 - DOI